Veritas Pharma Inc.

Recent News

  • Veritas Pharma Announces Preliminary Clinical Trial Results and the Company's New Direction

    Vancouver, British Columbia--(Newsfile Corp. - February 13, 2020) -  Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FSE: 2VP) ("Veritas" or the "Company") announces its preliminary human study results of its lead cannabis treatment for acute pain, CTL-X, as well as, the Company's new strategy going forward.Preliminary Results of Clinical TrialsThe ...

    2020-02-13 5:15 PM ET
  • Veritas Announces the Sale of the Sechelt Property

    Vancouver, British Columbia--(Newsfile Corp. - December 9, 2019) - Veritas Pharma Inc.'s (CSE: VRT) (OTC: VRTHF) (Frankfurt: 2VP) ("Veritas" or the "Company") is pleased to announce that its fully owned subsidiary the Sechelt Organic Marijuana Corp. has completed the sale of its property located in Sechelt, BC, to Lis Holdings ...

    2019-12-09 7:45 AM ET
  • Veritas' Proceeding to Build State-of-the-Art Cannabis Cultivation Facility

    Vancouver, British Columbia--(Newsfile Corp. - July 10, 2017) - Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (Frankfurt: 2VP) is pleased to announce that it is preparing to begin construction of a state-of-the-art cannabis growing facility upon receiving Health Canada's license under Access to Cannabis for Medical Purposes Regulations (ACMPR). Veritas ...

    2017-07-10 4:08 AM ET
  • Veritas Pharma Places Final Payment in Trust for the Acquisition of Cannevert Therapeutics

    Vancouver, British Columbia--(Newsfile Corp. - January 25, 2017) - Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP), an emerging discovery and IP development company, has announced that it has placed its final payment of $250,000 to Cannevert Therapeutics Ltd. (CTL) (scheduled for May 1st, 2017) into a trust ...

    2017-01-25 5:23 PM ET
  • Veritas Pharma Advances Fifth of Six Equal Payments to Cannevert Therapeutics Ltd.

    Vancouver, British Columbia--(Newsfile Corp. - January 23, 2017) - Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP), an emerging discovery and IP development company, is pleased to announce that it has completed its second to last payment of $250,000 to Cannevert Therapeutics Ltd. (CTL). This latest installment brings ...

    2017-01-23 6:04 PM ET
  • Veritas Receives Listing on the Xetra(R) (Frankfurt, Germany) Trading Venue

    Vancouver, British Columbia--(Newsfile Corp. - December 7, 2016) - Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP), an emerging discovery and IP development company, is pleased to announce that as of December 7th, 2016, its common shares are accepted for continuous trading on the electronic trading platform XETRA® ...

    2016-12-07 6:02 PM ET
  • Report on Canada's Marijuana Legalization is Anticipated to be Released This Week

    Vancouver, British Columbia--(Newsfile Corp. - November 29, 2016) - Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP) ("VRT" or the "Company") is eagerly awaiting the report of the Task Force on Marijuana Legalization to be delivered by its Chair, Anne McLellan to the Canadian Federal Cabinet by this ...

    2016-11-29 8:36 AM ET
  • Veritas Pharma Inc. Management Discussion and Analysis Amendment and Restatement

    Vancouver, British Columbia--(Newsfile Corp. - November 25, 2016) - Veritas Pharma Inc. (CSE: VRT) (OTC Pink: VRTHF) (FSE: 2VP), ("Veritas" or the "Company"), as a result of a review by the British Columbia Securities Commission, is issuing the following press release to clarify our disclosure. We have amended and restated ...

    2016-11-25 4:05 PM ET